SOCS3 and hyper-IgE syndrome: We report here two new DN IL6ST variants identified in patients with a clinical presentation of AD HIES, including one C-terminal to the Tyr759 SHP/SOCS3 binding site and to the first STAT3 binding site, but N-terminal to the recycling motif.